Phosphatidylserine (Sharp-PS).
It's a membrane phospholipid your brain cells are built from. Daily use is studied for recall, attention and a steady head after a demanding day.
Reviewed March 2026
- Category
- Phospholipid
What Phosphatidylserine (Sharp-PS) is, and what it does.
- Does it work
- Suits older adults wanting recall support and people under sustained mental load. It's a slow builder, so it belongs in a daily routine rather than the night before a big day.
- How much to take
- Start with 100 to 300mg a day. That band is where recall, attention and the cortisol response have been studied. The 600mg used in trials is a research condition.
- Time to feel it
- Give it four to twelve weeks. Cognitive measures in trials moved across that window, so this builds slowly rather than showing up on day three.
- The first dose
- Day one is uneventful. The lipid is cleaved and rebuilt in the gut wall before it reaches membranes, so the first day is groundwork rather than an effect.
- With regular use
- Across four to twelve weeks of daily use, cognitive measures in trials shifted gradually. What you get is a steadier baseline rather than a step change on a given day.
- How well tolerated
- Well tolerated in trials, with mild digestive upset the usual complaint. If you take blood thinners, or you're pregnant or breastfeeding, check with your doctor first.
- How it feels
- Most people report nothing dramatic. Where something is noticed it tends to be steadier recall and feeling less rattled after a demanding day, arriving over weeks.
- The overlooked benefit
- Swallowed phosphatidylserine does not arrive intact. It is broken down and rebuilt inside the gut wall, which is why the serine headgroup matters more than the attached fats.
100 to 300mg a day is where Phosphatidylserine (Sharp-PS) works.
Source: Kato-Kataoka 2010 + Glade 2015 cognitive review
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Phosphatidylserine (Sharp-PS) has emerging evidence. Based on 1+ studies.
- Memory and recall in older adultsRandomised trial
- Attention and behaviour measures in childrenRandomised trial
- Cortisol response to exercise stressRandomised trial
- Membrane docking platform for protein kinase C and AktIn vitro study
- Hydrolysis and re-esterification during absorptionNarrative review
Questions people ask about Phosphatidylserine (Sharp-PS).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Brain phosphatidylserine is heavily enriched with DHA at the sn-2 position, and DHA availability raises the phosphatidylserine content of neuronal membranes. The two are a structural pair rather than two separate actives.
Fish oil supplies the DHA that occupies the sn-2 position of neuronal phosphatidylserine. Supplying the head group and the acyl chain together matches how the membrane lipid is actually built.
EPA is incorporated into membrane phospholipids and also spares DHA from being drawn on for signalling lipids. That leaves more DHA available for phosphatidylserine assembly.
Phosphatidylserine is made by base-exchange, where serine swaps onto an existing phospholipid backbone in exchange for choline or ethanolamine. Serine is the literal head group substrate for that reaction.
The base-exchange enzymes that generate phosphatidylserine use phosphatidylcholine and phosphatidylethanolamine as the donor backbone. The two phospholipids interconvert within one membrane pool.
Citicoline feeds the Kennedy pathway that builds phosphatidylcholine, the backbone donor for phosphatidylserine formation. It also supplies choline for acetylcholine, a separate neuronal demand.
Alpha-GPC is a choline-carrying glycerophospholipid that enters the same membrane phospholipid pool. It supports both the backbone supply and acetylcholine synthesis.
Phosphatidylethanolamine is converted to phosphatidylcholine by three SAM-dependent methylation steps, and that phosphatidylcholine is a base-exchange donor. Methyl group supply therefore sits upstream of phospholipid turnover.
Ginkgo acts on cerebral blood flow and platelet activating factor signalling, while phosphatidylserine acts on membrane composition. The two mechanisms sit at different points and have been formulated together for decades.
Bacopa bacosides act on synaptic signalling and antioxidant handling in neural tissue rather than on membrane lipid supply. The pairing covers two separate layers of neuronal function.
ALCAR donates acetyl groups for acetylcholine synthesis and supports mitochondrial fatty acid handling in neurons. Phosphatidylserine works on the membrane those mitochondria and receptors sit in.
Phosphatidylserine blunts the cortisol response to physical stress, while theanine acts through GABAergic and alpha-wave activity. Both touch the stress response from different directions.
The head group of phosphatidylserine is L-serine, and the enzymes that make and interconvert serine run on pyridoxal 5-phosphate. Adequate B6 status therefore sits behind the body's own serine supply for phospholipid synthesis. Supplemental phosphatidylserine bypasses part of that, so this is a background sufficiency argument rather than an added effect.
Serine hands its beta carbon to tetrahydrofolate, which is where most methyl groups in the body originate. Phosphatidylserine metabolism therefore intersects the folate cycle at the serine node. This is shared biochemistry and not evidence that combining the two changes any measured outcome.
The route that converts phosphatidylethanolamine to phosphatidylcholine in the liver consumes three S-adenosylmethionine methyl groups, and B12 keeps the folate to methionine loop turning. That places B12 upstream of phospholipid remodelling generally. It supports normal phospholipid handling rather than adding to phosphatidylserine directly.
Serine hydroxymethyltransferase moves carbon between serine and glycine in both directions depending on cellular demand. Glycine intake therefore feeds the same pool the phosphatidylserine head group comes from. Neither amino acid alone builds the phospholipid, which also needs the diacylglycerol backbone.
Classical protein kinase C isoforms dock onto membranes through a calcium-bridged C2 domain that specifically recognises phosphatidylserine. This is the clearest example of phosphatidylserine acting as a signalling cofactor rather than a structural lipid. It is textbook biochemistry, not a supplement combination finding.
Phospholipid concentrates carry unsaturated fatty acids at the sn-2 position, and tocopherols are the usual in-product antioxidant for that reason. This protects the material in the bottle and during processing. It is a stability argument, and stability is not the same as an effect in a person.
Sunflower or soy lecithin supplies the phosphatidylcholine that phospholipase D converts to phosphatidylserine by swapping the head group for L-serine. Lecithin also appears in finished products as a dispersing agent for a sticky phospholipid powder. Adding lecithin does not add phosphatidylserine.
Phospholipids disperse and are absorbed with dietary lipid, which is why softgels use an oil carrier and why label instructions say to take with food. A rat study in this candidate set compared phospholipid, liposomal and MCT vehicles for other lipophilic actives and shows how much the vehicle can shift exposure. That work was in rats and used different actives, so it grounds the mechanism only.
Phosphatidylserine is routinely placed alongside caffeine in attention and focus formulas, where caffeine supplies the acute effect and the phospholipid is positioned as the structural component. The two act by unrelated mechanisms, adenosine receptor antagonism versus membrane phospholipid supply. Nothing in the sources listed here tests the pair together.
Tyrosine supplies the carbon skeleton for dopamine and noradrenaline, while phosphatidylserine is a membrane component of the terminals those transmitters are released from. The pairing puts a substrate next to a structural component. It is a mechanistic rationale and no combination trial appears in these sources.
Prothrombinase and tenase complexes require an anionic phosphatidylserine surface for the gamma-carboxyglutamate residues of vitamin K dependent factors to bind through calcium bridges. That is why phosphatidylserine exposure is the standard laboratory marker of a procoagulant membrane. This concerns membrane surfaces in vivo and does not mean an oral phospholipid supplement changes clotting; anyone on medication that affects clotting should raise it with their clinician.
Phosphatidylserine synthase swaps the choline head group of phosphatidylcholine for serine, so choline supply sits directly upstream of endogenous phosphatidylserine. Choline also becomes acetylcholine by a separate route. The two roles should not be blended when writing about a phospholipid formula.
Nothing specific on file for Phosphatidylserine (Sharp-PS). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Phosphatidylserine (Sharp-PS) actually does.
It normally sits on the inside face of a cell membrane, held there by pumps that keep the two faces different.
The body builds it by swapping the head group on a phospholipid it already has, and can convert it onward into another phospholipid.
Several signalling proteins can only switch on when they can grab hold of this particular lipid.
When it flips to the outside of a cell, other cells read that as a signal.
Where Phosphatidylserine (Sharp-PS) comes from.
Makers start with lecithin from sunflower or soy and use an enzyme to swap one part of the molecule for the amino acid serine. What ends up in the capsule is that rebuilt fat, usually mixed with a carrier powder.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Lecithin is a by-product of seed oil degumming; the L-serine used for the head-group exchange is normally produced by microbial fermentation
Crude lecithin is de-oiled and fractionated with alcohol to raise the phosphatidylcholine content that the enzyme needs
Phospholipase D, classically from cabbage or a Streptomyces strain, exchanges the choline head group for L-serine in a two-phase reaction
Unconverted phosphatidylcholine, free serine and reaction solvents are washed out and residual solvent is controlled to specification
Content is set by chromatography or phosphorus nuclear magnetic resonance and the concentrate is standardised, commonly to 20 or 50 percent on a carrier
Dried onto a carrier for capsules and tablets, dispersed in oil for softgels, or supplied as the DHA-bearing phospholipid
Branded grades usually disclose the lecithin source but not the enzyme source, the residual solvent profile, or the carrier fraction of the powder, and the carrier fraction is what decides how many milligrams of phospholipid a stated dose actually contains.
Getting Phosphatidylserine (Sharp-PS) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In older adults reporting everyday memory lapses, phosphatidylserine with omega-3 fatty acids over 15 weeks was linked to better memory recognition scores mainly within a subgroup starting from higher baseline performance, not across the whole group.Randomised trial. Richter et al., 2010 (Clinical interventions in aging). PMID 21103402 ↗
- A supplementation trial of sunflower-derived phosphatidylserine in healthy children measured cognitive test performance; the material is the sunflower form of the same molecule rather than a specific branded soy-derived grade, and cognitive test scores are measured outcomes in a defined age group.Randomised trial. Friling M et al., 2025 (Nutrition Journal). PMID 41318468 ↗
- In rats, phospholipid, liposomal and MCT vehicles gave different pharmacokinetic profiles for lutein and zeaxanthin, which supports the general point that a phospholipid vehicle changes exposure of a lipophilic compound; the actives tested were not phosphatidylserine.Animal study. Mehkri S et al., 2025 (Pharmaceutics). PMID 41471067 ↗
- A longitudinal study in people receiving regular transfusions in which phosphatidylserine exposure on red cell membranes appears as a measured laboratory marker; this describes phosphatidylserine as an endogenous membrane feature, not as a supplement being tested.Cohort study. Theocharaki K et al., 2026 (Blood Advances). PMID 41115240 ↗
These are the studies our verdict leans on, chosen from the 297 we read for Phosphatidylserine (Sharp-PS). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.